Vena Cava Thrombosis after Congenital Diaphragmatic Hernia Repair: Multivariate Analysis of Potential Risk Factors.


Journal

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie
ISSN: 1439-359X
Titre abrégé: Eur J Pediatr Surg
Pays: United States
ID NLM: 9105263

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 11 12 2021
medline: 26 2 2022
entrez: 10 12 2021
Statut: ppublish

Résumé

 The treatment of newborns with congenital diaphragmatic hernia (CDH) is associated with a significant complication rate. Information on major thrombotic complications and their incidence in newborns with CDH is lacking. The aims of our analysis were to evaluate the frequency of vena cava thrombosis and to determine its predictors within a consecutive series of patients with CDH.  We retrospectively analyzed charts of all neonates of our department that underwent CDH repair from 2007 to 2021, focusing on vena cava thrombosis. Vena cava thrombosis was diagnosed sonographically and classified as complete or partial venous occlusion. Complete occlusion was confirmed by cavography. Variables evaluated were CDH side, liver position, central vein line, surgical approach, and extracorporeal membrane oxygenation (ECMO). Univariate and multivariate tests were utilized.  Among 57 neonates who underwent CDH repair, vena cava thrombosis was diagnosed in 14 (24.6%), seven of whom had complete occlusion of the vena cava. Factors associated with vena cava thrombosis were femoral or saphenous venous catheter (  The incidence of vena cava thrombosis in newborns with CDH in our series is high. Routine postoperative abdominal sonography focusing on vena cava thrombosis is mandatory in all patients with CDH. Patients who developed vena cava thrombosis were more likely to develop chylothorax after CDH repair. Considering the good outcome of medical therapy of partial vena cava thrombosis, it may be discussed whether low dose anticoagulation may be provided to all newborns with CDH.

Identifiants

pubmed: 34891190
doi: 10.1055/s-0041-1740462
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-97

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared

Auteurs

Rim Kiblawi (R)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Niedersachsen, Germany.

Christoph Zoeller (C)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Niedersachsen, Germany.
Department of Pediatric Surgery, University Hospital Muenster, Muenster, Germany.

Sabine Pirr (S)

Department of Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.

Alejandro D Hofmann (AD)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Niedersachsen, Germany.

Benno Ure (B)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Niedersachsen, Germany.

Jens Dingemann (J)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Niedersachsen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH